About Nitish

Nitish Mittal is a Vice President in the technology practice covering digital transformation and applications. Based out of the London office, he covers horizontal technology areas across AI, automation, data & analytics, interactive services (IX), and IoT. With a background in serving biotech and private equity clients, Nitish helped incubate Everest Group’s healthcare and life sciences technology practice. In addition to leading the vendor evaluation (PEAK Matrix®) initiative, he works with enterprises, service providers, product firms, industry associations, and investment firms on problem statements such as deal constructs, go-to-market strategy, market positioning, business due diligence, sales enablement, and enterprise adoption benchmarking. Part of his responsibilities also include leading the firm’s thought leadership. Prior to Everest Group, Nitish worked in the advisory space for private equity and venture capital clients on market entry, portfolio assessment, and due diligence engagements. Nitish holds a bachelor’s degree in engineering from Delhi College of Engineering (DCE)

Nitish's recent reports

View All
Veeva Services PEAK Matrix® Assessment 2021

As an increasing number of pharmaceutical companies experiment with different ways to cut costs while boosting productivity amid the pandemic, the industry[...]

Read Report

Customer Data Platform Trailblazers: Top 15 Startups Redefining Hyper-personalization

Enterprises have long been investing in the MarTech landscape to provide better customer experiences. However, the[...]

Read Report

Connecting Life Sciences Manufacturing Using Industrial IoT

This viewpoint examines the digitization of the life sciences manufacturing value chain through the Industrial Internet of Things (IIoT). Th[...]

Read Report

From Dissatisfaction to Delight: Sustaining Client Satisfaction in the Post-pandemic World

Technology vendors emerged as true strategic partners to enterprises during COVID-19 in terms of helping the[...]

Read Report

Nitish's blog posts

View All

BioClinica and ERT to Merge: Perspectives on Potential Synergies

On December 10, 2020, ERT, a clinical end-point data solutions company, announced [...]

Read Post

Reflections on Cloudera Now and the Battle for Data Platform Supremacy

The enterprise data market is going through a pretty significant category revision, [...]

Read Post

GPT-3 Accelerates AI Progress, but the Path to AGI is Going to Be Bumpy

OpenAI recently released the third generation of Generative Pretrained Transformer or GPT-3, [...]

Read Post

COVID-19 Is Truly a Black Swan Event, and We Can’t Rely on History to Predict the Outcome

The last thing the world needs is another "hot-take" on COVID-19, but [...]

Read Post

How can we engage?

Please let us know how we can help you on your journey.

Contact Us

  • Please review our Privacy Notice and check the box below to consent to the use of Personal Data that you provide.